CNS-85 trial: A cooperative pediatric CNS tumor study - results of treatment of medulloblastoma patients

Child's Nervous System

Volumn 12, Issue 2, 1996, Pages 87-96

  Pezzotta, S ^a   Cordero Di Montezemolo, L ^b   Knerich, R ^a   Arrigoni, M ^c   Barbara, A ^b   Besenzon, L ^b   Brach Del Prever, A ^b   Fidani, P ^d   Locatelli, D ^a   Loiacono, G ^e   Magrassi, L ^a   Perilongo, G ^f   Rigobello, L ^f   Urgesi, A ^b   Madon, E ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c General Hospital   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chemotherapy; Children; Medulloblastoma; Radiotherapy

Indexed keywords

LOMUSTINE; METHOTREXATE; PROCARBAZINE; TENIPOSIDE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; AGE; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEDULLOBLASTOMA; MORTALITY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC AGENTS; CEREBELLAR NEOPLASMS; CEREBELLUM; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; ITALY; MALE; MEDULLOBLASTOMA; METHOTREXATE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIATION DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; VINCRISTINE;

EID: 13344279404     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00819502     Document Type: Article

References (32)

1. Allen JC, Bloom J, Ertel I, Evans A, Hammond D, Jones H, Levin V, Jenkin D, Sposto R, Wara W (1986) Brain tumors in children: current cooperation and institutional chemotherapy trials in newly diagnosed and recurrent disease. Semin Oncol 13:110-122
2. Belza MG, Donaldson SS, Steinberg GK, Cox RS, Cogen PH (1991) Medulloblastoma: freedom from relapse longer than 8 years - a therapeutic cure? J Neurosurg 75:575-582
3. Berry MP, Jenkin RDT, Keen CW, Nair BD, Simpson WJ (1981) Radiation treatment for medulloblastoma. A 21-year review. J Neurosurg 55:43-51
4. Bloom HJG (1981) SIOP medulloblastoma and high grade ependymoma therapeutic clinical trial: preliminary results. Proceedings of the XIII Meeting of the International Society of Paediatric Oncology, Marseilles
5. Bloom HJG, Wallace ENK, Henk JM (1969) The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases. Am J Roentgenol Radium Ther Nucl Med 105:43-62
6. Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93:1351-1359
7. Chin HW, Maruyama Y (1982) Prognostic factors in medulloblastoma. Am J Clin Oncol 5:359-369
8. Cox DR (1972) Regression models and life-tables (with discussion). J R Stat Soc [B] 34:187-220
9. Evans AE, Anderson J, Chang C, Jenkin RTD, Kramer S, Schoenfeld D, Wilson CB (1979) Adjuvant chemotherapy for medulloblastoma and ependymoma. In: Paoletti P, Walker MD, Butti G, Knerich R (eds) Multidisciplinary aspects of brain tumor therapy. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 219-222
10. Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL, Hammond GD (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572-582
11. Harisiadis L, Chang CH (1977) Medulloblastoma in children: a correlation between staging and results of treatment. Int J Radiat Oncol Biol Phys 2:833-841
12. Hershatter BW, Halpen EC, Cox EB (1986) Medulloblastoma: the Duke University Medical Center experience. Int J Radiat Oncol Biol Phys 12:1771-1777
13. Jenkin D, Goddard K, Armstrong D, Becker L, Berry M, Chan H, Doherty M, Greenberg M, Hendrick B, Hoffman H, Humphreys R, Soley M, Weizman S, Zipursky A (1990) Posterior fossa medulloblastoma in chidhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 19:265-274
14. Kanev PM, Berger MS, Lefebvre JF, Mauseth RS (1991) Growth hormone deficiency following radiation therapy of primary brain tumors in children. J Neurosurg 74:743-748
15. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
16. Knerich R, Adinolfi D, Buoncristiani P, Butti G, Calculli G, Cordero di Montezemolo L, Madon E, Mazza C, Tanghetti B, Tarenzi L (1979) Combined therapy for malignant brain tumors in children. J Neurosurg Sci 23:273-278
17. Krischer JP, Ragab AH, Kun L, Kim TH, Laurent JP, Boyett JM, Cornell CJ, Link M, Ridolfi Luthy A, Camitta B (1991) Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study. J Neurosurg 74:905-909
18. Levin VA, Rodriguez LA, Edwards MSB, Wara W, Liu HC, Fulton D, Davis RL, Wilson CB, Silver P (1988) Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine. J Neurosurg 68:383-387
19. McIntosh S, Chen M, Sartain PA, Duncan C, Fishburn R, Klatskin EH, Schwartz AD, Venes JL (1985) Adjuvant chemotherapy for medulloblastoma. Cancer 56:1316-1319
20. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207-214
21. Mulhern RK, Hancock J, Fairclough D, Kun L (1992) Neuropsychological status of children treated for brain tumors. A critical review and integrative analysis. Med Pediatr Oncol 20:181-191
22. Neidhardt MK, Bailey CC (1987) Prospective randomized cooperative medulloblastoma trial (MED 84) of the International Society of Paediatric Oncology (SIOP) and of the German Society of Paediatric Oncology (GPO). Child's Nerv Syst 3:70-73
23. Oberfield S, Allen J, Pollack J, New MI, Levine LS (1986) Long-term endocrine sequelae after treatment of medulloblastoma: prospective studies on growth and thyroid function J Pediatr 108:219-223
24. Packer RJ, Siegel KR, Sutton LN, Evans AE, D'Angio G, Rorke LB, Bunin GR, Schut L (1988) Efficacy of adjuvant chemotherapy for patients with poor risk medulloblastoma: a preliminary report. Ann Neurol 24:503-508
25. Packer RJ, Sutton LN, Golwein JW, Perilongo G, Bunin G, Rayan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA, Rorke LB, Evans AE, Schut L (1991) Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74:433-440
26. Park TS, Hoffmann HJ, Hendrick EB, Humphreys RB, Becker LE (1983) Medulloblastoma: clinical presentation and management - experience at the Hospital for Sick Children, Toronto 1950-1980. J Neurosurg 58:543-552
27. Peto R, Pike MC, Amitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPerson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39
28. Raimondi AJ, Tomita T (1979) Medulloblastoma in childhood. Acta Neurochir 50:127-138
29. Rivera-Luna R, Rueda-Franco F, Lanche-Guevara MT, Martinez-Guerra G (1987) Multidisciplinary treatment of medulloblastoma in childhood. Child's Nerv Syst 3:228-231
30. Silverman CL, Simpson JR (1982) Cerebellar medulloblastoma: the importance of posterior fossa dose to survival and patterns of failure. Int J Radiat Oncol Biol Phys 8:1869-1876
31. Tait DM, Thorton-Jones H, Bloom HJG, Lemerle J, Morris-Jones P (1990) Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464-469
32. Zeltzer PM (1986) Chemotherapy for medulloblastoma: a review of treatment in recurrent and de novo tumors. In: Zeltzer PM, Pochedly C (eds) Medulloblastomas in children: new concepts in tumor biology, diagnosis and treatment. Praeger, New York, pp 182-199